Denali Therapeutics Inc.

Symbole: DNLI

NASDAQ

20.86

USD

Prix du marché aujourd'hui

  • -14.6885

    Ratio P/E

  • -0.1573

    Ratio PEG

  • 2.88B

    Cap MRK

  • 0.00%

    Rendement DIV

Denali Therapeutics Inc. Structure de gestion

Informations sur la direction

Nom de l'entrepriseTitre de l'entreprise
Mr. Joe Lewcock Ph.D.Chief Scientific Officer
Mr. Tyler M. NielsenSenior Vice President of Corporate Finance
Dr. Dana AndersenChief Technical and Manufacturing Officer
Dr. Ryan J. Watts Ph.D.Co-Founder, President, Chief Executive Officer & Director
Dr. Carole Ho M.D.Chief Medical Officer & Head of Development
Dr. Laura HansenVice President of Investor Relations
Dr. Marc Tessier-Lavigne Ph.D.Co-Founder & Independent Director
Mr. Chris WalshGeneral Counsel
Mr. Mark RowenVice President of Corporate Development
Dr. Alexander O. Schuth M.D.Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary